Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Patient reported that Shingrix reactivated a previous episode of singles; shingles had affected his temporal nerve, causing a headache that lasted a year. Patient had to see a neurologist; This serious case was reported by a other health professional via sales rep and described the occurrence of shingles in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (had shingles). On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Patient reported that Shingrix reactivated a previous episode of singles) (serious criteria other: Serious as per reporter) and post herpetic neuralgia (Verbatim: shingles had affected his temporal nerve, causing a headache that lasted a year. Patient had to see a neurologist) (serious criteria other: Serious as per reporter). The outcome of the shingles was unknown and the outcome of the post herpetic neuralgia was resolved (duration 1 year). The reporter considered the shingles and post herpetic neuralgia to be related to Shingles vaccine. The company considered the shingles and post herpetic neuralgia to be unrelated to Shingles vaccine.; Sender's Comments: A case of Herpes zoster and Post herpetic neuralgia, an unknown time after receiving Shingles vaccine, in a male patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Further follow up information has been sought.
Medical History/Concurrent Conditions: Shingles (had shingles)